New York, New York, United States Related Funds
| Fund Name | Location |
| Bairong | Beijing, Beijing, China |
| eCandy.com | - |
| Galaxy Capital | China, Jiangsu, Suzhou |
| GO Capital Fund | Canada, Montréal, Quebec |
| Hafnium Hafaway | - |
| Hubei Qianyong Touzi | China, Hubei, Wuhan |
| Institute for Interdisciplinary Information Core Technology | - |
| Khattar Holdings | Central, Central Region, Singapore |
| Kogito Ventures | Mazowieckie, Poland, Warsaw |
| LTS | Japan, Tokyo |
| New Kent Capital LLC. | - |
| RBC Capital Markets | Albany, New York, United States |
| Reinet Investments S.C.A. | Luxembourg, Luxembourg |
| Ronald Lauder Ventures | - |
| Runyang Group | China, Guangdong Province, Luohu District |
| Slate Path Capital | New York, New York, United States |
| Synopsys | California, Mountain View, United States |
| UCLA Investment Company | California, Los Angeles, United States |
| Wenxin Shiye | China, Guangdong, Jiangxi |
| Yabeo Capital | Bavaria, Bayern, Germany |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Arcellx | $115M | 13 Apr 2021 | Maryland, United States | ||
Pipeline Therapeutics | $80M | 11 Feb 2021 | San Diego, California, United States | ||
HemoShear Therapeutics | $40M | 10 Feb 2021 | Charlottesville, Virginia, United States | ||
Terns Pharmaceuticals | $87M | 05 Jan 2021 | California, United States | ||
| $60M | 28 Sep 2020 | Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Arcellx | $115M | 13 Apr 2021 | Maryland, United States | ||
Pipeline Therapeutics | $80M | 11 Feb 2021 | San Diego, California, United States | ||
HemoShear Therapeutics | $40M | 10 Feb 2021 | Charlottesville, Virginia, United States | ||
Terns Pharmaceuticals | $87M | 05 Jan 2021 | California, United States | ||
| $60M | 28 Sep 2020 | Shanghai |
